Jordi Rovira

20PUBLICATIONS
51CO-AUTHORS
Haematological tumoursMajor global burdens of diseasePredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Radiation therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (20)

|Sep 03, 2026
Chimeric HLA Antibody Receptor (CHAR) T Cells to Specifically Eliminate HLA-DQ-Specific B Cells.

|May 13, 2026
Common Biomarkers of Endothelial Dysfunction Across Highly Prevalent Diseases with Cardiovascular Risk: Functional Characterization and Prognostic Implications.

|Feb 27, 2026
Dried Blood Spot for CXCL-10 and Tacrolimus: Integrated Non-Invasive Monitoring to Guide Personalized Treatment in Adult Kidney Transplant Recipients.

Olga Millán, Jordi Rovira, Virginia Fortuna

|Jan 09, 2026
Chimeric Antigen Receptor T-Cell Therapy: More Than an Anti-Cancer Drug.

Hannah C M Schenk, Ilse Gille, Carolt Arana

|Dec 22, 2025
Extracorporeal photopheresis for refractory BK virus-associated nephropathy in kidney transplantation.

Víctor J Escudero-Saiz, Marc Xipell, Ángela González

|Oct 29, 2025
Tacrolimus-Associated Tremor in Renal Transplant Patients: Potential Impact of the Galenic Formulation.

Jordi Rovira, Olga Millán, Pedro Ventura-Aguiar

Pageof 4

Frequent Collaborators

7 joint publications

Pedro Ventura-Aguiar

7 joint publications

Fritz Diekmann

4 joint publications

Carolt Arana

3 joint publications

Diana Rodriguez-Espinosa